{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:55:34Z","timestamp":1772726134199,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cpcardiol.2022.101550","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T02:45:14Z","timestamp":1671158714000},"page":"101550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Qualitative and Quantitative Effects of PCSK9 Inhibitors in familial Hypercholesterolemia: a Synthetic Review"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-3047","authenticated-orcid":false,"given":"Aamina","family":"Shakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Barron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalgi","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101550_bib0001","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical Genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0002","series-title":"Robbins Basic Pathology","year":"2018"},{"issue":"3 Suppl","key":"10.1016\/j.cpcardiol.2022.101550_bib0003","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"National lipid association expert panel on familial hypercholesterolemia. familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0004","unstructured":"OMIM Entry - # 143890 - HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1. Accessed January 3, 2022.https:\/\/omim.org\/entry\/143890?search=%22familial%20hypercholesterolemia%22&highlight=%22familial%20%28hypercholesterolaemia%7Chypercholesterolemia%29%22"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0005","unstructured":"Familial Hypercholesterolemia: Cardiovascular risk stratification and clinical management - american college of cardiology. Accessed January 3, 2022. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/06\/01\/13\/54\/familial-hypercholesterolemia"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0006","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the american college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0007","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.numecd.2015.06.007","article-title":"Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis","volume":"25","author":"Di Taranto","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15420\/ecr.2014.9.2.76","article-title":"Department of medicine, emory university school of medicine, Atlanta, GA, US, Sandesara P, et al. current treatment of familial hypercholesterolaemia","volume":"9","author":"Lambert","year":"2014","journal-title":"Eur Cardiol Rev"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0009","series-title":"Basic & Clinical Pharmacology","year":"2021"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0010","series-title":"StatPearls","article-title":"PCSK9 inhibitors","author":"Pokhrel","year":"2021"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0011","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0012","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-Week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0013","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0014","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3803\/EnM.2021.964","article-title":"Role of PCSK9 inhibitors in patients with familial hypercholesterolemia","volume":"36","author":"Tomlinson","year":"2021","journal-title":"Endocrinol Metab Seoul Korea"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0016","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.amjcard.2017.12.040","article-title":"Efficacy and Safety of alirocumab in high-risk patients with clinical atherosclerotic cardiovascular disease and\/or heterozygous familial hypercholesterolemia (from 5 placebo-controlled ODYSSEY trials)","volume":"121","author":"McCullough","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jacl.2016.12.004","article-title":"Efficacy and safety of the proprotein convertase subtilisin\/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia","volume":"11","author":"Kastelein","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0018","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0019","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa1614062","article-title":"Lipid-reduction variability and antidrug-antibody formation with bococizumab","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacl.2019.05.005","article-title":"Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. a consensus statement from the national lipid association","volume":"13","author":"Robinson","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jacl.2020.03.001","article-title":"PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study","volume":"14","author":"Daniels","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2022.101550_bib0022","author":"Amgen","year":"2021"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622004479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622004479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:02:25Z","timestamp":1758938545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622004479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0146280622004479"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101550","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative and Quantitative Effects of PCSK9 Inhibitors in familial Hypercholesterolemia: a Synthetic Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101550"}}